ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Other Current Assets
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Other Current Assets of -$719.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2023-11-13
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2023-09-30 was $1.70M.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2023-06-30 was -$851.00K, a 423.57% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2023-03-31 was -$1.56M, a 1472.81% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2022-12-31 was $2.22M, a 90.89% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2022 was $1.23M, a 136.08% increase from fiscal 2021.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2021 was $521.00K, a 17.43% decline from fiscal 2020.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2020 was $631.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2019 was -$4.81K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 9 month as first filed | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $846.00K derived: sum of 2 quarters · filed 2023-11-13 | -$719.00K 10-Q · filed 2023-11-13 | $1.50M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2023-06-30 | -$851.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.42M 10-Q · filed 2023-08-14 | -$194.00K derived: sum of 3 quarters · filed 2023-08-14 | -$1.56M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2023-03-31 | -$1.56M 10-Q · filed 2023-05-15 | $657.00K derived: sum of 2 quarters · filed 2023-05-15 | -$712.00K derived: sum of 3 quarters · filed 2023-11-13 | -$449.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $853.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.12M derived: sum of 3 quarters · filed 2023-11-13 | $1.23M 10-K · filed 2023-03-22 | ||||
| 2022-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.11M derived: sum of 2 quarters · filed 2023-11-13 | -$992.00K 10-Q · filed 2023-11-13 | -$395.00K 10-Q · filed 2022-11-07 | $172.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $377.00K 10-Q · filed 2023-08-14 | $974.00K 10-Q · filed 2022-08-08 | $1.54M derived: sum of 3 quarters · filed 2023-08-14 | $1.48M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $114.00K 10-Q · filed 2023-05-15 | $1.28M derived: sum of 2 quarters · filed 2023-05-15 | $1.22M derived: sum of 3 quarters · filed 2023-05-15 | $1.22M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.10M derived: sum of 2 quarters · filed 2023-03-22 | $1.10M derived: sum of 3 quarters · filed 2023-03-22 | $521.00K 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$61.00K derived: sum of 2 quarters · filed 2022-11-07 | -$643.00K 10-Q · filed 2022-11-07 | -$643.41K 10-Q · filed 2021-11-15 | -$164.78K derived: sum of 4 quarters · filed 2022-11-07 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$582.00K 10-Q · filed 2022-08-08 | -$582.59K 10-Q · filed 2021-08-13 | -$103.78K derived: sum of 3 quarters · filed 2022-08-08 | -$188.83K derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | -$582.00K 10-Q · filed 2022-05-09 | -$581.17K 10-Q · filed 2021-05-14 | -$103.78K derived: sum of 2 quarters · filed 2022-05-09 | -$188.83K derived: sum of 3 quarters · filed 2022-05-09 | -$59.39K derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $478.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $393.17K derived: sum of 2 quarters · filed 2022-02-28 | $522.61K derived: sum of 3 quarters · filed 2022-02-28 | $631.00K 10-K · filed 2022-02-28 | $631.53K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | -$85.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $44.39K derived: sum of 2 quarters · filed 2021-11-15 | $152.78K 10-Q · filed 2021-11-15 | $176.85K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $129.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $237.83K 10-Q · filed 2021-08-13 | $261.89K derived: sum of 3 quarters · filed 2021-08-13 | $263.82K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $108.39K 10-Q · filed 2021-05-14 | $132.46K derived: sum of 2 quarters · filed 2021-05-14 | $134.38K derived: sum of 3 quarters · filed 2021-05-14 | $106.56K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $24.07K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $25.99K derived: sum of 2 quarters · filed 2021-03-31 | -$1.83K derived: sum of 3 quarters · filed 2021-03-31 | -$4.81K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $1.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$25.89K derived: sum of 2 quarters · filed 2020-11-13 | -$28.88K 10-Q · filed 2020-11-13 | -$217.53K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | -$27.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$30.80K 10-Q · filed 2020-08-13 | -$219.46K derived: sum of 3 quarters · filed 2020-08-13 | -$48.46K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$2.98K 10-Q · filed 2020-05-13 | -$191.64K derived: sum of 2 quarters · filed 2020-05-13 | -$20.64K derived: sum of 3 quarters · filed 2020-05-13 | -$25.77K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$188.65K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$17.66K derived: sum of 2 quarters · filed 2020-03-26 | -$22.79K derived: sum of 3 quarters · filed 2020-03-26 | -$74.30K 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $165.87K derived: sum of 2 quarters · filed 2019-11-13 | $114.35K 10-Q · filed 2019-11-13 | $220.59K derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$5.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$56.64K 10-Q · filed 2019-08-13 | $49.59K derived: sum of 3 quarters · filed 2019-08-13 | $49.59K derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$51.51K 10-Q · filed 2019-05-13 | $54.73K derived: sum of 2 quarters · filed 2019-05-13 | $54.73K derived: sum of 3 quarters · filed 2019-05-13 | $54.73K derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $106.24K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $106.24K derived: sum of 2 quarters · filed 2019-03-28 | $106.24K derived: sum of 3 quarters · filed 2019-03-28 | $80.41K 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2017-11-13 | $3.00 derived: sum of 2 quarters · filed 2018-11-13 | -$25.83K 10-Q · filed 2017-11-13 | -$39.61K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $3.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-11-13 | -$25.83K 10-Q/A · filed 2018-11-13 | -$39.61K derived: sum of 3 quarters · filed 2018-11-13 | -$60.26K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-03-31 | -$25.83K 10-Q · filed 2018-05-14 | -$39.61K derived: sum of 2 quarters · filed 2018-05-14 | -$60.26K derived: sum of 3 quarters · filed 2018-05-14 | -$60.12K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | -$13.78K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$34.42K derived: sum of 2 quarters · filed 2018-03-08 | -$34.29K derived: sum of 3 quarters · filed 2018-03-08 | -$144.95K 10-K · filed 2018-03-08 | -$124.30K 10-K · filed 2017-03-16 | |||
| 2016-09-30 | -$20.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$20.51K derived: sum of 2 quarters · filed 2017-11-13 | -$131.18K 10-Q · filed 2017-11-13 | -$24.97K derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $135.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$110.53K 10-Q · filed 2017-08-14 | -$4.32K derived: sum of 3 quarters · filed 2017-08-14 | -$4.32K derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$110.66K 10-Q · filed 2017-05-11 | -$4.46K derived: sum of 2 quarters · filed 2017-05-11 | -$4.45K derived: sum of 3 quarters · filed 2017-05-11 | -$128.36K derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $106.21K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $106.21K derived: sum of 2 quarters · filed 2017-03-21 | -$17.70K derived: sum of 3 quarters · filed 2017-03-21 | $110.66K 10-K/A · filed 2017-03-21 | ||||
| 2015-09-30 | $2.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -$123.90K derived: sum of 2 quarters · filed 2017-03-21 | $4.46K 10-Q/A · filed 2017-03-21 | |||||
| 2015-06-30 | -$123.91K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21 | $4.45K 10-Q/A · filed 2017-03-21 | ||||||
| 2015-03-31 | $128.36K 10-Q/A · filed 2017-03-21 | |||||||
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |